USFDA have approved a new drug made by Roach, which could be given to patients with late-stage metastatic breast cancer who fail to respond to other therapies
Sun Pharmaceutical Industries announced today that it has received US FDA approval to market a generic version of Doxil injection, used for treating ovarian cancer in the American market
An international study has revealed the potential of new skin cancer treatment Zelboraf, which is one of only a handful of melanoma drugs to reach the market in 13 years